Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...

The Lysosomal Storage Disease Treatment Market is expanding due to increased diagnosis rates and innovations in enzyme ...

Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with ...

After a leading study caused the FDA to slap its most stringent warning on hormone replacement therapies for menopause more ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock ...

Morgan showed the video to her doctor, and following tests, Lydia was diagnosed with Sanfilippo syndrome B — often called ...